Topics

8/1/19

Gabriela K. Popescu, PhD, professor of biochemistry, will use funding from the National Institutes of Health (NIH) to study the gating mechanisms of fast neurotransmitter brain receptors.

5/10/19

L. Nelson “Nick” Hopkins, MD, SUNY Distinguished Professor of neurosurgery, has been awarded the Chancellor Charles P. Norton Medal, the University at Buffalo’s highest honor.

5/6/19

Four Jacobs School of Medicine and Biomedical Sciences faculty members have been selected as recipients of 2019 SUNY Chancellor’s Awards for Excellence.

4/16/19
Researchers have developed a way to generate 3D prints of the human vascular system, giving surgeons pre-surgical, hands-on access to individual patients’ life-threatening vascular diseases in the heart and brain.
3/12/19

The Jacobs School of Medicine and Biomedical Sciences is among 72 sites nationwide that are recruiting patients for a 12-week, randomized, placebo-controlled drug trial for the first treatment designed to benefit patients with mild-to-moderate Lewy body dementia (LBD).

3/4/19

Thirty-four original research projects from aspiring physician-scientists were on display at the 2019 Medical Student Research Forum.

2/22/19

Gil I. Wolfe, MD, UB Distinguished Professor and Irvin and Rosemary Smith Chair of the Department of Neurology, has been elected president of the New York State Neurological Society (NYSNS).

11/20/18

Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

10/25/18

Chelsey Reed, a student in the MD-PhD Program, has been awarded a prestigious fellowship from the National Institutes of Health (NIH).

9/14/18

New information from Department of Biochemistry researchers on how manganese gets into the brain is helping to shed light on a neurological disorder usually associated with industrial overexposure to the metal.

8/3/18

Researchers at the Hunter James Kelly Research Institute (HJKRI) have been awarded a pair of grants for the investigation of mechanisms underlying axonal degeneration in certain neurological disorders.

6/13/18

Stephen Rudin, PhD, SUNY Distinguished Professor of radiology and director of radiation physics, has been named a fellow of SPIE, the International Society for Optics and Photonics.

5/24/18

UB’s Clinical and Translational Science Institute (CTSI) has awarded new grants that support promising translational research projects in Western New York.

3/22/18

A total of 37 original research projects from aspiring physician-scientists were on display at the 2018 Medical Student Research Forum.

2/14/18

Department of Biochemistry researchers have changed the understanding of metal ion metabolism in mitochondria through a collaborative study whose results were published in Scientific Reports.

2/13/18

Findings published in JAMA Neurology show that in stroke patients with large vessel occlusion (LVO), the removal of the clot occurs as efficiently after aspiration-based clot removal alone as it does after aspiration-based clot removal performed with a stent retriever.

2/6/18

Three Jacobs School of Medicine and Biomedical Sciences faculty members performed surgeries that were broadcast live to the Vascular Interventional Advances (VIVA) Conference in Las Vegas.

1/29/18

Adnan Siddiqui, MD, PhD, vice chair and professor of neurosurgery and one of the lead investigators in the COMPASS trial, presented preliminary results at the International Stroke Conference in Los Angeles that show evidence that aspiration-based thrombectomy is a safe and effective alternative for patients with acute ischemic stroke.

8/1/17

M. Laura Feltri, MD, professor of biochemistry and neurology, is leading research to determine whether a new family of molecules prevents demyelination and nerve degeneration in patients with peripheral nerve diseases.

6/13/17

Surgeons and researchers sharing facilities in UB’s Clinical and Translational Science Institute and Kaleida Health’s Gates Vascular Institute (GVI) is resulting in collaboration, synergy and world-class innovation.